Literature DB >> 19700427

Running an international paediatric non-commercial clinical trial.

J P Osborne1, F J K O'Callaghan.   

Abstract

The current regulations for conducting non-commercial clinical trials in Europe are many and complex. These are explored from the perspective of a UK based non-commercial international clinical trial. The reasons for the difficulties encountered are discussed and suggestions made as to how best to overcome them. Improvements are suggested for our law makers and competent authorities. It is argued that the current regulatory environment could be considered unethical as it inhibits and delays research.

Mesh:

Year:  2009        PMID: 19700427     DOI: 10.1136/adc.2008.148494

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

1.  Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.

Authors:  James D Neaton; Abdel Babiker; Mark Bohnhorst; Janet Darbyshire; Eileen Denning; Arnie Frishman; Jesper Grarup; Gregg Larson; Jens Lundgren
Journal:  Clin Trials       Date:  2010-08-20       Impact factor: 2.486

2.  Academic pediatric clinical research: factors associated with study implementation duration.

Authors:  Delphine Meier-Girard; Annick Tibi; Hendy Abdoul; Sonia Prot-Labarthe; Françoise Brion; Olivier Bourdon; Corinne Alberti
Journal:  BMC Med Res Methodol       Date:  2016-03-29       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.